Načítá se...
Treatment With Calcineurin Inhibitor FK506 Attenuates Noise-Induced Hearing Loss
Attenuation of noise-induced hair cell loss and noise-induced hearing loss (NIHL) by treatment with FK506 (tacrolimus), a calcineurin (CaN/PP2B) inhibitor used clinically as an immunosuppressant, has been previously reported, but the downstream mechanisms of FK506-attenuated NIHL remain unknown. Her...
Uloženo v:
| Vydáno v: | Front Cell Dev Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7994600/ https://ncbi.nlm.nih.gov/pubmed/33777956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.648461 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|